close 73% inwestorów detalicznych traci pieniądze podczas handlu CFD z tym dostawcą. Inwestowanie wiąże się z ryzykiem i nie jest odpowiednie dla wszystkich inwestorów. Kontrakty CFD są złożonymi instrumentami i wiążą się z dużym ryzykiem szybkiej utraty środków pieniężnych z powodu dźwigni finansowej. 73% rachunków inwestorów detalicznych notuje stratę pieniędzy podczas handlu kontraktami CFD z tym dostawcą. Upewnij się, czy rozumiesz, jak działają kontrakty CFD, i czy możesz pozwolić sobie na wysokie ryzyko utraty pieniędzy.
Change languagePolski
Pulpit

MDT

100.66

+1.04%↑

A

148.25

+0.84%↑

VEEV

237.14

+2.05%↑

HQY

96.61

+2.61%↑

PHR.US

17.24

-0.58%↓

MDT

100.66

+1.04%↑

A

148.25

+0.84%↑

VEEV

237.14

+2.05%↑

HQY

96.61

+2.61%↑

PHR.US

17.24

-0.58%↓

MDT

100.66

+1.04%↑

A

148.25

+0.84%↑

VEEV

237.14

+2.05%↑

HQY

96.61

+2.61%↑

PHR.US

17.24

-0.58%↓

MDT

100.66

+1.04%↑

A

148.25

+0.84%↑

VEEV

237.14

+2.05%↑

HQY

96.61

+2.61%↑

PHR.US

17.24

-0.58%↓

MDT

100.66

+1.04%↑

A

148.25

+0.84%↑

VEEV

237.14

+2.05%↑

HQY

96.61

+2.61%↑

PHR.US

17.24

-0.58%↓

Strona główna・Stock List・Seres Therapeutics Inc
Search

Seres Therapeutics Inc

Closed

SectorHealthcare

15.38 1.38

Buy

Price update 6 sty 2026, 20:59 UTC

BuySell

Overview

Share price change

24h

Current

Min

15.02

Max

15.65

Key metrics

By Trading Economics

Income

28M

8.2M

Sales

351K

351K

P/E

Sector Avg

16.955

88.032

EPS

0.94

Profit margin

2,337.322

Employees

103

EBITDA

28M

9.3M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+44.83% upside

Market Stats

By TradingEconomics

Market Cap

1.6M

135M

Previous open

14

Previous close

15.38

News Sentiment

By Acuity

33%

67%

92 / 373 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Bearish Evidence

N/A / 9.31 Support & Resistance

Seres Therapeutics Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

6 sty 2026, 21:14 UTC

Major Market Movers

Ventyx Biosciences Gains on Report of Possible $1 Billion Eli Lilly Deal

DJ

Read

6 sty 2026, 19:23 UTC

Acquisitions, Mergers, Takeovers

OneStream to Go Private Through $6.4 Billion Hg Acquisition

DJ

Read

6 sty 2026, 17:41 UTC

Major Market Movers

Blink Charging Shares Rise as EV Chargers Begin Accepting Cryptocurrency

DJ

Read

6 sty 2026, 15:46 UTC

Acquisitions, Mergers, Takeovers

Advent International Leads InPost Takeover Offer, Sky News Says

DJ

Read

6 sty 2026, 15:37 UTC

Major Market Movers

Terrestrial Energy Shares Rise After DOE Agreement For Nuclear Plant Development

DJ

Read

6 sty 2026, 23:46 UTC

Market Talk

Nikkei May Decline After Hitting Record High -- Market Talk

DJ

Read

6 sty 2026, 23:35 UTC

Market Talk

Gold Edges Higher Amid Ongoing Geopolitical Tensions -- Market Talk

DJ

Read

6 sty 2026, 23:19 UTC

Market Talk

Greatland 2Q Gold Output Strong, Sales Soft -- Market Talk

DJ

Read

6 sty 2026, 22:53 UTC

Market Talk

WiseTech, REA and CAR Look Best Insulated From AI Threat -- Market Talk

DJ

Read

6 sty 2026, 22:03 UTC

Acquisitions, Mergers, Takeovers

Staar Surgical: Merger Proposal Received 14.9M Votes For and 27.3M Against

DJ

Read

6 sty 2026, 22:03 UTC

Acquisitions, Mergers, Takeovers

Staar Surgical, Which Earlier Reported Stockholder Rejection of Sale to Alcon, Reports Vote Totals

DJ

Read

6 sty 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

DJ

Read

6 sty 2026, 21:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

DJ

Read

6 sty 2026, 21:12 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

DJ

Read

6 sty 2026, 21:12 UTC

Market Talk

Commodity Demand Helps Canada Reduce Reliance on Trade With U.S. -- Market Talk

DJ

Read

6 sty 2026, 20:59 UTC

Major Market Movers
Acquisitions, Mergers, Takeovers

Ventyx Biosciences Gains on Report of Possible $1B Eli Lilly Deal

DJ

Read

6 sty 2026, 20:40 UTC

Acquisitions, Mergers, Takeovers

Acquisition of Ventyx Would Bring Lilly Into Emerging Category of Pills for Inflammation-Related Conditions -- WSJ

DJ

Read

6 sty 2026, 20:40 UTC

Acquisitions, Mergers, Takeovers

Eli Lilly Nears Deal for Biotech Ventyx -- WSJ

DJ

Read

6 sty 2026, 20:40 UTC

Acquisitions, Mergers, Takeovers

Deal Could Be Announced Imminently, Sources Say -- WSJ

DJ

Read

6 sty 2026, 20:40 UTC

Acquisitions, Mergers, Takeovers

Eli Lilly in Advanced Talks to Buy Ventyx Biosciences For Over $1B, Sources Say -- WSJ

DJ

Read

6 sty 2026, 20:01 UTC

Market Talk

Oil Futures Give Back Post-Venezuela Incursion Gains -- Market Talk

DJ

Read

6 sty 2026, 19:52 UTC

Market Talk

U.S. Natural Gas Falls Awaiting Colder Weather -- Market Talk

DJ

Read

6 sty 2026, 19:46 UTC

Acquisitions, Mergers, Takeovers

Under Armour Stock Rises After the 'Warren Buffet of Canada' Boosts Its Stake -- Barrons.com

DJ

Read

6 sty 2026, 19:08 UTC

Acquisitions, Mergers, Takeovers

OneStream to Go Private Through $6.4B Hg Acquisition

DJ

Read

6 sty 2026, 18:28 UTC

Acquisitions, Mergers, Takeovers

These Stocks Are Moving the Most Today: Sandisk, Nvidia, AMD, Palantir, OneStream, SoFi, Microchip, and More -- Barrons.com

DJ

Read

6 sty 2026, 17:20 UTC

Market Talk
Earnings

Financial Services Roundup: Market Talk

DJ

Read

6 sty 2026, 17:20 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Health Care Roundup: Market Talk

DJ

Read

6 sty 2026, 15:57 UTC

Market Talk

Crude Futures Ease Back From Early Gains -- Market Talk

DJ

Read

6 sty 2026, 15:34 UTC

Market Talk
Earnings

Bank of Montreal Expects to Exit 2027 With ROE Hitting 15% Target -- Market Talk

DJ

Read

6 sty 2026, 15:27 UTC

Market Talk

German Inflation Won't Fall Much Further in 2026 -- Market Talk

DJ

Read

Peer Comparison

Price change

Seres Therapeutics Inc Forecast

Price Target

By TipRanks

44.83% upside

12 Months Forecast

Average 22 USD  44.83%

High 22 USD

Low 22 USD

Based on 2 Wall Street analysts offering 12 month price targets forSeres Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

2 ratings

2

Buy

0

Hold

0

Sell

Based on 2 analysts giving stock ratings to Seres Therapeutics Inc - Dist in the past 3 months.

Technical Score

By Trading Central

N/A / 9.31Support & Resistance

Short Term

Bearish Evidence

Recent bearish events outweigh bullish events.

Intermediate Term

Bearish Evidence

All events are bearish.

Long Term

Bearish Evidence

All events are bearish.

Sentiment

By Acuity

92 / 373 Ranking in Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

Other stocks from the sector

MDT

Medtronic PLC

100.66

↑ +1.04%

A

Agilent Technologies Inc

148.25

↑ +0.84%

VEEV

Veeva Systems Inc

237.14

↑ +2.05%

HQY

HealthEquity Inc

96.61

↑ +2.61%

PHR.US

Phreesia Inc

17.24

↓-0.58%
help-icon Live chat